pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 63 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    (minoxidil + finasteride + latanoprost)
    (minoxidil + finasteride + latanoprost)
    Androgenic Alopecia Triple Hair Inc
  • Phase 2
    (plerixafor + tacrolimus)
    (plerixafor + tacrolimus)
    Wounds MedRegen LLC
  • Phase 2
    ABS-201
    Androgenic Alopecia Almirall SA
  • Phase 2
← prev
page 1 of 3
next →
131
Pain89
Neurology1
AGLE-102
Burns
Aegle Therapeutics Corp
  • Phase 2
    ALY-101
    Alopecia Areata Alys Pharmaceuticals Inc
  • Phase 2
    AMTX-100
    Atopic Dermatitis (Atopic Eczema) Amytrx Therapeutics Inc
  • Phase 2
    ATR-04
    Skin Rash$AZTR Azitra, Inc.
  • Phase 2
    BCX-17725
    Netherton Syndrome (Bamboo Hair)$BCRX BIOCRYST PHARMACEUTICALS INC
  • Phase 2
    BLU-808
    Chronic Inducible Urticaria Blueprint Medicines Corp
  • Phase 2
    CBL-514
    Adiposis Dolorosa (Dercum's Disease or Anders Disease) Caliway Biopharmaceutics Co Ltd
  • Phase 2
    CX-001
    Nevus Calissa Therapeutics
  • Phase 2
    DLQ-01
    Androgenic Alopecia Dermaliq Therapeutics Inc
  • Phase 2
    ELU-42
    Diabetic Foot Ulcers Eluciderm Inc
  • Phase 2
    EVO-756
    Chronic Inducible Urticaria$EVMN Evommune, Inc.
  • Phase 2
    EXG-34217
    Dyskeratosis Congenita (Zinsser-Cole-Engman Syndrome) Elixirgen Therapeutics Inc
  • Phase 2
    FB-825
    Atopic Dermatitis (Atopic Eczema) Oneness Biotech Co Ltd
  • Phase 2
    IMB-101
    Hidradenitis Suppurativa Navigator Medicines Inc
  • Phase 2
    IMG-007
    Atopic Dermatitis (Atopic Eczema)$IMA ImageneBio, Inc.
  • Phase 2
    ISN-001
    Diabetic Foot Ulcers Anterogen Co Ltd
  • Phase 2
    KT-621
    Eosinophilic Asthma$KYMR Kymera Therapeutics, Inc.
  • Phase 2
    LUT-014
    Acne And Related Disorders Lutris Pharma
  • Phase 2
    MC-232
    Hidradenitis Suppurativa MC2 Therapeutics AS
  • Phase 2
    MDI-1228
    Diabetic Foot Ulcers Henan Maiyingnuo Pharmaceutical Technology Co Ltd
  • Phase 2
    MTX-001
    Venous Leg Ulcers (Crural Ulcer) Merakris Therapeutics Inc
  • Phase 2
    NanoDOX
    NanoDOX
    Wounds Resilience Government Services Inc
  • Phase 2
    Nu-3
    Diabetic Foot Ulcers Lakewood-Amedex Inc
  • Phase 2
    NuGel
    Atopic Dermatitis (Atopic Eczema) Hudson Therapeutics Inc
  • Phase 2
    OLX-101A
    Hypertrophic Scars OliX Pharmaceuticals Inc
  • Phase 2
    P-12
    Burns NeoMatrix Therapeutics Inc
  • Phase 2
    PH-10
    Xantryl
    Atopic Dermatitis (Atopic Eczema)$PVCT PROVECTUS BIOPHARMACEUTICALS, INC.